Atrial fibrillation (AF) is a common arrhythmia associated with increased risk of stroke and
mortality. The early appearance of electrical remodeling is followed by structural remodeling …

Background—Data from studies of angiotensin-converting enzyme inhibitors provide
evidence that the renin-angiotensin-aldosterone system plays a role as a mediator of atrial …

Atrial fibrillation is the most common disorder of cardiac rhythm. In spite of diagnosis
simplicity, patients with atrial fibrillation are difficult to treat. In the recent years with the …

Atrial fibrillation (AF) is the most common clinical arrhythmia, and is difficult to treat. Current
treatment strategies are far from optimal. Antiarrhythmic drug therapy to maintain sinus …

Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in clinical
practice, affecting approximately 250,000 Canadians and accounting for more than 120,000 …

Background Experimental studies suggest that angiotensin II-receptor blockers can
influence atrial remodeling and may prevent atrial fibrillation (AF). Therefore, we …

The purpose of this study was to examine the relationship between long-term efficacy of
amiodarone therapy (100-200 mg/day) combined with angiotensin converting enzyme …

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT• Atrial fibrillation (AF) is the most
common rhythm disturbance in medical practice.• AF can be managed with the prevention of …

Objectives: The purpose of the present study was to evaluate the effect of angiotensin II type
1 receptor (AT1R) antagonist on chronic structural remodeling in atrial fibrillation (AF) …

In managing atrial fibrillation (AF), the main therapeutic strategies include rate control,
termination of the arrhythmia, and the prevention of recurrences and thromboembolic …